TCBIO
TEXAS CAPITAL BANCSHARES INC/TX
$20.34
-1.17%
$898.7M
No data for this timeframe.
Vol
Market Cap$898.7M
Cap SizeSmall Cap
SEC Reports2
Recent Activity
Apr 23, 2026
SEC
Texas Capital Bancshares reported strong first-quarter 2026 results with 63% year-over-year earnings growth and declared
8-K — Impact 8/10
Mar 30, 2026
SEC
Texas Capital Bancshares is holding its annual shareholder meeting on April 21, 2026, with a key proposal to redomestica
DEFA14A — Impact 3/10
Analyst Ratings
4Strong Buy
5Buy
7Hold
2Sell
1Strong Sell
Latest Reports
BULLISH
8-K
8/10
Texas Capital Bancshares reported strong first-quarter 2026 results with 63% year-over-year earnings growth and declared
Apr 23, 2026
NEUTRAL
DEFA14A
3/10
Texas Capital Bancshares is holding its annual shareholder meeting on April 21, 2026, with a key proposal to redomestica
Mar 30, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 47% buy across 19 analysts — 4 strong buy, 5 buy, 7 hold, 2 sell, 1 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 8.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 1.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.3B | 7.3% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.4B | 6.7% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 5 | 7 | 2 | 1 | 47% | |
| May 1, 2026 | 4 | 5 | 7 | 2 | 1 | 47% | |
| Apr 1, 2026 | 4 | 5 | 8 | 2 | 1 | 45% | |
| Mar 1, 2026 | 4 | 5 | 8 | 2 | 1 | 45% | |
| Feb 1, 2026 | 4 | 5 | 7 | 2 | 1 | 47% | |
| Jan 1, 2026 | 4 | 5 | 8 | 2 | 1 | 45% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.